Journal ArticleOPEN ACCESS

The use of biomarkers in Alzheimer's disease: a case report

Progress in Neurology and Psychiatry (2019) 23(3) 10-14
DOI: 10.1002/pnp.540
1Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Uncertainties remain around the use of biomarkers in clinical practice to diagnose Alzheime's disease. There are several implications for both patients and clinicians, including the ethical and practical dilemmas of identifying a disease process early in its course when there are no disease-modifying treatments available.

Cite

CITATION STYLE

APA

Stanley, K., Stevens, T., & Walker, Z. (2019). The use of biomarkers in Alzheimer’s disease: a case report. Progress in Neurology and Psychiatry, 23(3), 10–14. https://doi.org/10.1002/pnp.540

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free